Regeneron Pharmaceuticals (REGN) Q2 2025 Earnings

29AprConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
8.22
9.63
11.05
12.46

Details

Expected EPS
8.621716
Actual EPS
8.22
Surprise EPS
-0.4
Surprise Percent
+4.66%

Description

Regeneron Pharmaceuticals (REGN) has reported earnings of 8.22 per share for Q2 2025.

0 Comments

Share your thoughts